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The serine protease tissue-type plasminogen activator (tPA) is used as a thrombolytic
agent in the management of ischemic stroke, but concerns for hemorrhagic conversion
greatly limits the number of patients that receive this treatment. It has been suggested
that the bleeding complications associated with thrombolytic tPA may be due to
unanticipated roles of tPA in the brain. Recent work has suggested tPA regulation
of neurovascular barrier integrity, mediated via platelet derived growth factor (PDGF)-
C/PDGF receptor-α (PDGFRα) signaling, as a possible molecular mechanism affecting
the outcome of stroke. To better understand the role of tPA in neurovascular regulation
we conducted a detailed analysis of the cerebrovasculature in brains from adult tPA
deficient (tPA−/−) mice. Our analysis demonstrates that life-long deficiency of tPA is
associated with rearrangements in the cerebrovascular tree, including a reduction in
the number of vascular smooth-muscle cell covered, large diameter, vessels and a
decrease in vessel-associated PDGFRα expression as compared to wild-type (WT)
littermate controls. In addition, we found that ablation of tPA results in an increased
number of ERG-positive endothelial cells and increased junctional localization of the tight
junction protein ZO1. This is intriguing since ERG is an endothelial transcription factor
implicated in regulation of vascular integrity. Based on these results, we propose that the
protection of barrier properties seen utilizing these tPA−/− mice might be due, at least in
part, to these cerebrovascular rearrangements. In addition, we found that tPA−/− mice
displayed mild cerebral ventricular malformations, a feature previously associated with
ablation of PDGF-C, thereby providing an in vivo link between tPA and PDGF signaling
in central nervous system (CNS) development. Taken together, the data presented here
will advance our understanding of the role of tPA within the CNS and in regulation of
cerebrovascular permeability.
Keywords: tPA, PDGF, blood-brain barrier, neurovascular unit, neurovascular coupling, lateral ventricles, ERG,
vascular permeability
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INTRODUCTION
The serine protease tissue-type plasminogen activator (tPA)
is primarily known for its role in fibrinolysis via proteolytic
activation of plasminogen into plasmin (Collen, 2001). The
observation that tPA directly binds to fibrin (van Zonneveld
et al., 1986; Verheijen et al., 1986) and thereby facilitates
localized generation of plasmin has led to the use of tPA
as a thrombolytic agent for treatment of acute myocardial
infarction and ischemic stroke (Collen, 2001). In fact, tPA
administration is the only FDA-approved thrombolytic therapy
for acute ischemic stroke (The national institute of neurological
disorders and stroke rt-PA stroke study group, 1995; Su et al.,
2009). The use of thrombolytic tPA in ischemic stroke is
however markedly limited due to concerns for hemorrhagic
complications and the requirement that it is administered
within a few hours of onset of symptoms (The national
institute of neurological disorders and stroke rt-PA stroke study
group, 1995; Ahmed et al., 2010). The mechanism by which
thrombolytic tPA might lead to hemorrhagic transformation of
ischemic stroke is not completely understood, but it appears
to be due in part to unique activities that tPA has in the
brain beyond its well established role in fibrinolysis (Nicole
et al., 2001; Wang et al., 2003; Yepes et al., 2003; Su et al.,
2009).
The role of tPA within the central nervous system (CNS)
is controversial (Su et al., 2009; Yepes et al., 2009; Lemarchant
et al., 2012; Schielke and Lawrence, 2012). It has been proposed
that tPA directly affects multiple processes, including neuronal
development/plasticity/excitotoxicity (Tsirka et al., 1996; Seeds
et al., 2003; Li et al., 2013), microglial activation (Tsirka
et al., 1997; Rogove and Tsirka, 1998), as well as regulation of
cerebrovascular permeability (Yepes et al., 2003; Su et al., 2008).
In a recent paper, we proposed that the neurovascular events
regulated by tPA might provide a unifying pathway for many
of these pleotropic effects of tPA in the CNS (Fredriksson et al.,
2015). We argued that tPA-induced changes in cerebrovascular
permeability might lead to a loss of precise control of the
extracellular environment, which in turn, might promote
dysregulation of neuronal signaling pathways (Fredriksson et al.,
2015).
To better understand the role of tPA in cerebrovascular
regulation we have conducted a detailed analysis of the
cerebrovasculature and the neurovascular unit in brains from
adult tPA deficient (tPA−/−) mice. We demonstrate that tPA
deficiency is associated with abnormal cerebral vascularization,
including a reduction in the amount of large diameter vessels.
In addition, we found a significant reduction of platelet derived
growth factor receptor-α (PDGFRα) expression around cerebral
vessels of tPA−/− mice which is particularly interesting given our
previous findings showing that the effect of tPA in regulation
of cerebrovascular permeability is mediated via activation of
platelet derived growth factor (PDGF)-C/PDGFRα signaling on
perivascular astrocytes (Fredriksson et al., 2004, 2005; Su et al.,
2008). Intriguingly, we also found that ablation of tPA results in
increased number of ERG-positive endothelial cells. ERG (ETS
related gene) is a member of the ETS family of transcription
factors implicated in vascular development (reviewed in Randi
et al., 2009) and overexpression of ERG in vivo was recently
shown to reduce vascular permeability (Birdsey et al., 2015). In
addition, we found that tPA−/− mice displayed mild cerebral
ventricular malformations, a feature previously associated with
ablation of PDGF-C (Fredriksson et al., 2012), thereby providing
an in vivo link between tPA and PDGF signaling in CNS
development. These findings will aid in our understanding of the
role of tPA in the CNS.
MATERIALS AND METHODS
Animal Strains
Age- and gender-matched tPA deficientmice (tPA−/−; Carmeliet
et al., 1994), back-crossed at least 10 generations into C57BL/6J
background, and their wild-type (WT) littermate controls
obtained from heterozygous breedings were used. All animal
experiments were approved by the local committee for animal
experiments at the University of Michigan, USA, and the studies
were conducted in accordance with the United States Public
Health Service’s Policy on Humane Care and Use of Laboratory
Animals.
Immunostaining and Confocal Microscopy
Tissue preparation for sectioning and immunostaining were
conducted using standard protocols. Mice were anesthetized with
isoflurane and following transcardial perfusion fixation with 4%
paraformaldehyde (PFA) in phosphate buffered saline (PBS) the
brains were removed and postfixed in 4% PFA 1 h at room
temperature (RT) and then kept in 30% sucrose, 4◦C overnight.
For immunofluorescence, vibratome sections (50 µm) were
cut and stained free floating in 24-well plates. The sections
were permeabilized and blocked with 1% bovine serum albumin
(BSA) in 0.5% TritonX-100/PBS overnight at 4◦C, followed
by incubation with primary antibodies in blocking solution
overnight at 4◦C (1:200 dilution). After thorough washes the
sections were incubated with fluorescent-conjugated secondary
antibodies overnight at 4◦C. The specific primary antibodies
used were: aquaporin 4 (AB2218; Millipore, Billerica, MA,
USA), α-smooth muscle actin (ASMA)-Cy3 (C6198; Sigma-
Aldrich, St. Louis, MO, USA), CD13 (MCA2183; AbD Serotec,
Oxford, UK), CD31 (553370; BD Biosciences, Franklin Lakes, NJ,
USA), ERG1 (ab92513; Abcam Plc, Cambridge, UK), collagen
IV (21501470; AbD Serotec), glial fibrillary acidic protein
(GFAP; Z0334; Dako, Glostrup, Denmark), glucose transporter 1
(GLUT1; sc-1605; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), PDGFRα (AF1062; R&D Systems, Minneapolis, MN,
USA), podocalyxin (AF1556; R&D Systems), and ZO1 (339100;
Invitrogen, Molecular Probes). For S100B (Z0311; Dako) antigen
retrieval was performed by boiling 10 min in target retrieval
solution (S1700; Dako). Appropriate fluorophore-conjugated
secondary antibodies were used for multi color detection
(Alexa Fluor 488, 568 and 647; Life Technologies, Molecular
Probes, Grand Island, NY, USA) and DAPI (4′,6-Diamidino-2-
Phenylindole, Dihydrochloride, 0.2 µg/ml) was included in the
last PBS wash to visualize the nuclei. The sections were then
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mounted on Superfrost Plus slides (Thermo Fisher Scientific
Inc., Waltham, MA, USA) with ProLong Gold Antifade reagent
(P36930; Life Technologies). All stainings were repeated two-
four independent times.
All images were acquired at RT with a Zeiss LSM700 confocal
microscope or a Zeiss Axio Observer Z1 inverted microscope
and the ZEN 2009 software (Carl Zeiss Microimaging GmbH,
Jena, Germany). Stained brain sections from tPA−/− mice (n = 5)
and WT littermates (n = 5) were analyzed by two independent
investigators blinded to the study group. In addition, as a
control of the quantification at least one set of images from
each respective staining was reanalyzed by a second blinded
investigator. n indicates the number of individual mice used in
the study. The individual observations are based on analysis of
four-eleven fields of view (same number of images per animal
and settings for each respective staining within an individual
experiment). The fields of view were taken in comparable
anatomic positions in each animal and the anatomic position
to be imaged was identified using the DAPI channel. The
anatomic positions analyzed were from brain regions where high
levels of tPA expression has been reported, including cortex,
hippocampus and amygdala (Yu et al., 2001). We did not
find any evidence of sub-regional effects or differences during
our analysis. The images were processed and analyzed using
Volocity 3D image analysis software (PerkinElmer, Waltham,
MA, USA), Photoshop CS5 (Adobe, San Jose, CA, USA) or
ImageJ64 (National Institutes of Health, Bethesda, MD, USA).
For quantification of antibody immunoreactivity using intensity,
all images were acquired using the same settings (within the
respective staining experiment) and the number of pixels above
a set threshold was determined. Each field of view analyzed was
from a maximum intensity Z-stack image (15–22 µm stack) or
from an epifluorescent image. The result from all the fields of
view in a given animal was averaged to obtain the value for that
individual. Individual values and group mean± SEM are shown.
The images shown are representative of the respective staining.
Detailed information regarding all the stainings and analysis
performed is summarized in the supplementary table 1 (Table
S1). Brightness and contrast settings were changed to generate
the final image and were applied equally to the entire image and
within the same set of images.
Magnetic Resonance Imaging Scans
All magnetic resonance imaging scans (MRI) were conducted
at the Center for Molecular Imaging, Department of Radiology,
University of Michigan. During the imaging procedure the mice
were anesthetized with isoflurane and the body temperature was
maintained using forced heated air. The MRI examinations were
performed in a 7.0T Varian MR scanner (183-mm horizontal
bore, Varian, Palo Alto, CA, USA). A double-tuned volume
radiofrequency coil was used to scan the head region of the mice.
Coronal T2-weighted images were acquired using a fast spin-
echo sequence with the following parameters: repetition time
(TR)/effective echo time (TE), 4000/60 ms; echo spacing, 15 ms;
number of echoes, 8; field of view (FOV), 20×20 mm; matrix,
256×128; slice thickness, 0.5 mm; number of slices, 25; and
number of scans, 1 (total scan time ∼2 min.). Photoshop and
Image J were used to assess differences in ventricular area and
the analysis was conducted blinded.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6.0
statistical software (GraphPad Software, La Jolla, CA, USA).
Statistical significance was determined by student’s unpaired t-
test and P values less than 0.05 were considered statistically
significant and are indicated in the figures by asterisks.
RESULTS
tPA Deficiency Affects Cerebral Vessel Size
A growing body of evidence is showing that tPA is both necessary
and sufficient to regulate cerebrovascular permeability (Yepes
et al., 2003; Su et al., 2008; Fredriksson et al., 2015). In order
to gain a better understanding of the role of tPA in controlling
cerebrovascular events we performed a thorough analysis of
the vascular bed in brain sections from tPA deficient (tPA−/−)
mice. Immunofluorescent stainings using CD31 antibodies, a
marker for vascular endothelial cells, revealed an abnormal
vascularization in the brains of adult tPA−/− mice (n = 5)
compared to littermate WT controls (n = 5; Figure 1A). In
tPA−/− brains the vascular bed showed an apparent decrease
in large diameter vessels (arrowheads) and increase in small
diameter vessels (arrows) relative to WT mice (Figure 1A). This
was confirmed by quantification of the CD31 stainings, showing
a significant decrease (P < 0.01) in vessel diameter in tPA−/−
mice (4.75 ± 0.2 µm) as compared to WT littermate controls
(6.03 ± 0.3 µm; Figure 1B). This decrease in average vessel size
in tPA−/− mice was due to a significant reorganization of the
vascular bed in tPA−/− brains relative to WT littermate controls,
with increased number of small diameter vessels (<5 µm;
WT = 54 ± 6% vs. tPA−/− = 67 ± 4%, P < 0.05) and fewer
large diameter vessels (>10 µm; WT = 10 ± 1% vs. tPA−/− = 1
± 0.8%, P < 0.01; Figure 1C). This was accompanied with an
overall, but non-significant (P = 0.31), reduction in the total
amount of CD31 staining in tPA−/− brains (80 ± 12% of WT)
compared to WT littermate controls (Figure 1D). Staining with
podocalyxin antibodies, another marker of vascular endothelial
cells, confirmed the loss of large diameter vessels (arrowheads)
and increase in small diameter vessels (arrows) in tPA−/− brains
relative to WT littermate controls (Figures 1E,F).
tPA Deficiency is Associated with
Increased Number of ERG-Positive
Endothelial Cells and Enhanced Junctional
Localization of ZO1 in the Murine Brain
In order to characterize whether the cerebrovascular changes
seen in tPA−/− mice were associated with altered number of
endothelial cells we conducted immunofluorescent stainings
using antibodies against the endothelial transcription factor ERG.
Unexpectedly, we found an apparent increase in the number of
ERG-positive cells in the brains of tPA−/− mice (n = 5) relative
toWT littermate controls (n = 5; Figure 2A). This was confirmed
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FIGURE 1 | Decreased number of large diameter vessels in tPA−/− brains. Immunofluorescent staining of murine brain sections from tPA−/− deficient mice
n = 5) and wild-type (WT) littermate controls (WT, n = 5) with (A–D) the endothelial cell marker CD31 and (E–F) podocalyxin (Podo) showed fewer large diameter
vessels (arrowheads) and increased number of small diameter vessels (arrows) in tPA−/− mice compared to WT littermate controls. Quantification of the CD31
staining from four confocal Z-stacks per animal revealed that the average vessel diameter was significantly lower in tPA−/− brains as compared to WT littermate
controls (B) and that there was a significant redistribution toward smaller diameter vessels in the cerebrovasculature of tPA−/− mice (C). The number of vessels
analyzed is displayed on the respective bars. There was no significant difference in the overall amount of CD31 positive staining as quantified by pixel intensity (D).
Staining with podocalyxin confirmed the results seen with staining for CD31 (E–F). The data shown are representative quantifications of four to nine maximum
intensity confocal Z-stacks per animal from four independent staining experiments with CD31 and Podocalyxin, respectively. The images display (A,F) maximum
intensity projections generated from confocal Z-stacks (22 µm) and (E) stitched tiling of epifluorescent images (taken with 10× objective). Cell nuclei were visualized
with DAPI. Data presented as mean ± SEM. Statistical significance was determined by student’s unpaired t-test. ∗P < 0.05; ∗∗P < 0.01; ns = non significant relative
to control. Scale bars (A,F) left panels, 50 µm; right panels, 20 µm, (E) 1 mm. Arbitrary units, A.U.
by quantification of the number of ERG-positive cells, showing
a significant (P < 0.01) overall increase in the tPA−/− mice
(20.2± 1.2 ERG+ cells/field of view) compared to WT littermate
controls (15.2 ± 0.6 ERG+ cells/field of view; Figure 2B). To
ensure that the increase of ERG-positive cells was not due to
an increase in the number of small vessels in tPA−/− brains,
we normalized the number of ERG+ cells to the amount of
CD31 staining. This verified that there were significantly more
(P < 0.01) ERG+ cells in the cerebral vessels of tPA−/− mice
(149± 11% of WT; Figure 2C). This was particularly interesting
since ERG has been implicated in vascular development, control
of vascular permeability and maintenance of the integrity of the
endothelial junctions (Randi et al., 2009; Birdsey et al., 2015).
We therefore investigated the appearance of endothelial tight
junctions in tPA−/− mice by immunofluorescent stainings using
antibodies against the tight junction protein ZO1. We found that
ZO1 appeared to show an increased junctional localization in
vessels in tPA−/− brains compared to WT littermate controls
(Figure 2D), suggesting that tPA−/− mice might have tighter
endothelial cell-cell junctions.
tPA Deficiency Leads to a Redistribution in
Vascular Mural Cell Coverage
Mural cells on the cerebral vascular tree include vascular
smooth muscle cells (vSMCs) and capillary pericytes. These cells
are known to play important roles in cerebrovascular events,
including maintenance of the blood-brain barrier (BBB; Armulik
et al., 2010; Daneman et al., 2010) and in regulation of vessel
diameter and blood flow (Kornfield and Newman, 2014; Hill
et al., 2015). To assess the distribution of vascular mural cell
coverage on cerebral vessels in tPA−/− mice we performed
immunofluorescent stainings using antibodies against ASMA,
a marker for vSMCs, and CD13, a marker for pericytes. The
stainings showed an apparent shift in the size of ASMA+ vessels,
with more ASMA+ small diameter vessels (arrows) and fewer
ASMA+ large diameter vessels (arrowheads) in tPA−/− brains
(n = 5) compared to WT littermate controls (n = 5; Figure 3A).
There was no significant difference in the overall amount of
ASMA+ staining (P = 0.46; Figure 3B) but the average diameter
of ASMA+ vessels was significantly smaller (P< 0.01) in tPA−/−
mice (15.4 ± 0.7 µm) as compared to WT littermate controls
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FIGURE 2 | Increased number of ERG+ endothelial cells and enhanced tight junction staining in tPA−/− mice. (A) Immunofluorescent stainings of murine
brain sections from tPA−/− mice (n = 5) and WT littermate controls (WT, n = 5) with antibodies for the endothelial transcription factor ERG showed what appeared to
be increased number of endothelial cells in tPA−/− mice as compared to WT littermate controls. (B–C) This was confirmed through quantification of the number of
ERG+ nuclei from four maximum intensity confocal Z-stacks per animal. This revealed that there was significantly more ERG-positive cells in tPA−/− brains compared
to WT littermate controls (B), also when normalized to CD31 staining as quantified by pixel intensity (arbitrary units, A.U.) (C). The data shown are representative
quantifications of four to nine maximum intensity confocal Z-stacks per animal from two independent staining experiments. (D) Staining with antibodies against the
tight junction protein ZO1 illustrated increased junctional expression in cerebral vessels in tPA−/− mice as compared to WT littermate controls. The images display
maximum intensity projections generated from confocal Z-stacks (22 µm). Data presented as mean ± SEM. Statistical significance was determined by student’s
unpaired t-test and ∗∗P < 0.01 relative to control. Scale bars (A,D) 20 µm.
(22.9± 1.3 µm; Figure 3C). tPA−/− mice displayed significantly
increased numbers of ASMA+ small diameter vessels (<15 µm;
WT = 17 ± 8% vs. tPA−/− = 61 ± 6%, P < 0.01) and fewer large
diameter vessels (>30 µm; WT = 19 ± 3% vs. tPA−/− = 5 ±
1%, P < 0.01; Figure 3D). The microvascular capillaries in the
adult murine brain of tPA−/− mice appeared to have normal
coverage of pericytes as visualized by immunostainings with
CD13 antibodies (arrows, Figure 3E). However, CD13 antibodies
also stain vSMC in larger vessels (arrowheads, Figure 3E) and
these vessels are essentially lost in tPA−/− mice, resulting in
an overall reduction in CD13 staining relative to WT littermate
controls (P < 0.05; Figure 3F).
The Basement Membrane and Astrocyte
Distribution is not Affected by tPA
Deficiency
To determine whether tPA deficiency affects the basement
membrane and/or perivascular astrocyte distribution we
analyzed sections from tPA−/− andWT littermate control brains
stained with antibodies directed against collagen IV, a marker
of the basement membrane; GFAP, a marker for astrocytes; and
aquaporin 4 (AQP4), a marker of perivascular astrocytic endfeet.
These analyses revealed what appeared as normal distribution
of basement membrane around similar sized vessels in tPA−/−
mice (Figure 4A). Further, we detected similar distribution of
GFAP+ astrocytes in the parenchyma (arrowheads) as well as
GFAP+ perivascular astrocytes associated with comparable sized
vessels (arrows) in the brains of tPA−/− mice relative to WT
littermate controls (Figure 4B). This was supported by stainings
of astrocytic endfeet with AQP4 showing apparently normal
perivascular astrocyte coverage in vessels of comparable size
(Figure 4C).
tPA Deficiency is Associated with Reduced
Levels of Vessel-Associated PDGFRα
Expression
Due to our previous findings showing that the effect of tPA
in regulation of cerebrovascular permeability is mediated via
activation of PDGFRα signaling on perivascular astrocytes in
the neurovascular unit (Fredriksson et al., 2004, 2005, 2015;
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FIGURE 3 | Decreased number of large diameter ASMA+ vessels in tPA−/− brains. (A) Immunofluorescent staining of murine brain sections from mice tPA−/−
(n = 5) and WT littermates (n = 5) with the vascular smooth muscle cell (vSMC) marker for alpha-smooth muscle actin (ASMA) displayed a redistribution of
ASMA-positive (ASMA+) vessels in tPA−/− mice compared to WT littermate controls. There appeared to be more ASMA+ vessels with smaller diameter (arrows) in
tPA−/− brains and fewer large ASMA+ diameter vessels (arrowheads) commonly seen in WT brains. (B–D) Quantification of the ASMA staining from eleven confocal
images per animal revealed that there was no significant difference in the overall amount of ASMA staining as quantified by pixel intensity (B), although the average
vessel diameter was significantly lower in tPA−/− brains as compared to WT littermate controls (C). In addition, there was a significant redistribution toward smaller
diameter ASMA+ vessels in the cerebrovasculature of tPA−/− mice compared to WT littermate controls (D). The number of vessels analyzed is displayed on the
respective bars. The data shown are representative quantifications of four to eleven confocal images per animal from three independent staining experiments.
(E) Staining with the vascular mural cell marker CD13, which stains pericytes, revealed that large diameter vessels positive for CD13, normally present in WT control
brains (arrowheads), was essentially lost in tPA−/− brains. However, the pericyte coverage of capillaries appeared normal (arrows). (F) The loss of large diameter
CD13+ vessels resulted in a significant reduction in CD13 staining in tPA−/− brains (n = 5) compared to WT littermate controls (n = 5). Quantification of CD13 pixel
intensity was made from nine confocal Z-stacks per animal. The data shown are representative quantifications of four to nine maximum intensity confocal Z-stacks
per animal from three independent staining experiments. The images display (A,E) maximum intensity projections generated from confocal Z-stacks (22 µm). Cell
nuclei were visualized with DAPI and vessels with podocalyxin (Podo). Data presented as mean ± SEM. Statistical significance was determined by student’s unpaired
t-test. ∗P < 0.05; ∗∗P < 0.01; ns = non significant relative to control. Scale bars (A,E) left and middle panels, 50 µm; right panels, 20 µm. Arbitrary units, A.U.
Su et al., 2008) we investigated the expression of PDGFRα
in tPA−/− brains. Immunofluorescent stainings for PDGFRα
displayed a reduction of PDGFRα expression around vessels
(arrows) in tPA−/− mice compared to WT littermate controls
(Figure 5A). Quantification of the total amount and vessel-
associated PDGFRα expression revealed that there was no
significant difference (P = 0.38) in the total amount of PDGFRα+
staining between tPA−/− mice and WT littermate controls
(Figure 5B). Perivascular PDGFRα expression was on the other
hand significantly reduced in tPA−/− mice (21 ± 8% of WT) as
compared to WT littermate controls (P < 0.05; Figure 5C).
Asymmetry of the Cerebral Lateral
Ventricles and Distorted Ependymal Lining
in tPA Deficient Mice
During the characterization of the tPA−/− mice we noted
that these mice presented with asymmetric LV (Figure 6)
similar to what we recently reported for Pdgfc−/− mice on
C57BL/6 background (Fredriksson et al., 2012). Analysis of
brain sections from tPA−/− mice (n = 5) by DAPI staining
revealed that the abnormal LV (arrowheads) coincided with
a hypoplastic septum, a defect that was not noted in any
WT animals (n = 5; arrow, Figure 6A). To ensure that the
ventricular abnormalities were not artifacts of tissue preparation,
in vivo MRI in live mice was employed. Figure 6B shows
the montage from MRI scans of one adult WT mouse (upper
panel) and two tPA−/− mice (middle and lower panels).
These MR scans illustrate displacement of the septum towards
the side of the smaller ventricle in one of the tPA−/−
brains (arrowhead) and a hypoplastic septum in the other
tPA−/− mouse (arrow, Figure 6B). This displacement of the
septum in the tPA−/− mice made the smaller ventricle appear
compressed. Comparing the total area of the smallest to
the largest ventricle from the MR scans revealed significant
asymmetry of the LV (P < 0.05) in the tPA−/− mice
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FIGURE 4 | Normal basement membrane and astrocyte distribution in tPA−/− mice. Immunofluorescent staining of murine brain sections from tPA−/− mice
(n = 5) and WT littermate controls (n = 5) was conducted with antibodies directed against (A) collagen IV, a marker of the basement membrane, (B) glial fibrillary
acidic protein (GFAP), a marker for astrocytes, and (C) aquaporin 4 (AQP4), a marker of perivascular astrocytic endfeet. These analyses revealed normal distribution
of basement membrane (A) and perivascular astrocytes (arrows, B,C) around similar sized vessels in tPA−/− mice and WT littermates. In addition, normal distribution
of parenchymal astrocyte staining (arrowheads, B) was detected. The pictures are representative maximum intensity projections images generated from confocal
Z-stacks from stainings on brain sections from WT and tPA−/− mice and the stainings have been repeated at least two independent times. Cell nuclei were visualized
with DAPI and vessels with podocalyxin (Podo) or CD31. Scale bars 20 µm.
(70 ± 5%, n = 13) as compared to WT littermate controls (86 ±
4%, n = 10; Figure 6C), thus confirming the observation from the
DAPI analysis. The ventricular abnormalities seen in the tPA−/−
mice appeared to be milder when compared to the asymmetry of
the LV reported in Pdgfc−/− mice (56 ± 6%; Fredriksson et al.,
2012).
In adult mammals, the cerebral ventricles are normally
lined by a single layer of uninterrupted ciliated squamous to
columnar ependymal cells, which form the interface between
the brain parenchyma and the ventricular cavities (Bruni,
1998). Based on the above findings of lateral ventricle
abnormalities in the tPA−/− mice we then examined the
integrity of the ependymal cell lining in adult tPA mutant
mice. In the tPA−/− mice (n = 5) we noted that the
ependymal lining, here visualized by the ependymal marker
S100B (Bruni, 1998), was distorted and that the normal
cuboidal shape of ependymal cells was often lost in the
tPA−/− animals (arrows, Figure 6D). The ependymal lining
appeared pleomorphic in tPA−/− mice and did not form
a uniform single layer as seen in WT littermate controls
(n = 5; arrowheads, Figure 6D). This was further confirmed
by immunostaining with podocalyxin (Podo) showing that
the strong apical border staining seen in WT ependyma was
abnormal and distorted in tPA−/− mice (Figure 6D, middle
panels). Unlike what we saw in the Pdgfc−/− mice, we did
not find any signs of ependymal denudation or decreased
expression in glucose transporter 1, GLUT1, (a marker for
mature ependyma; Silva-Alvarez et al., 2005) in the ventricular
wall of tPA−/− mice. On the contrary, our analysis showed an
increase in GLUT1 staining in the ventricular wall (indicated
by the dashed lines) in tPA−/− mice (n = 5) compared
to WT littermate controls (n = 5; Figure 6E). This was
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FIGURE 5 | Decreased expression of perivascular PDGFRα in brains of tPA−/− mice. (A) Immunofluorescent staining of murine brain sections from tPA−/−
deficient mice (n = 5) and WT littermate controls (WT, n = 5) with antibodies directed against PDGFRα displayed fewer PDGFRα-positive (PDGFRα+) vessels (arrows)
in tPA−/− mice compared to WT littermate controls. (B–C) Quantification of the PDGFRα staining by pixel intensity from nine maximum intensity confocal Z-stacks
per animal revealed that there was no significant difference in the overall amount of PDGFRα staining (B), but that perivascular PDGFRα expression was significantly
reduced in tPA−/− mice as compared to WT littermate controls (C). The number of PDGFRα+ vessels analyzed is displayed on the respective bars. The data shown
are representative quantifications of nine maximum intensity confocal Z-stacks per animal and images from epifluorescent tiles of the entire brain from three
independent staining experiments. The images display maximum intensity projections generated from confocal Z-stacks (22 µm). Cell nuclei were visualized with
DAPI and vessels with podocalyxin (Podo). Data presented as mean ± SEM. Statistical significance was determined by student’s unpaired t-test and ∗P < 0.05;
ns = non significant relative to control. Scale bars 20 µm. Arbitrary units, A.U.
confirmed by quantification of the ventricular GLUT1 staining
(P < 0.05; tPA−/− = 580 ± 144% of WT; Figure 6F).
Further, the ependymal cells in the ventricular walls normally
display a punctate pattern of ZO1 distribution, indicative
of discontinuous tight junctions (Petrov et al., 1994). This
punctate pattern was seen in the WT littermate controls
(arrowheads, Figure 6G), but in tPA−/− mice, the ZO1 staining
indicated continuous tight junctions between the ependymal
cells (arrows, Figure 6G). Quantification of the ZO1 staining
showed significantly increased levels of ZO1 (P < 0.01) in
the ventricular wall of tPA−/− mice (n = 5) compared to
WT littermate controls (n = 5; tPA−/− = 363 ± 62% of WT;
Figure 6H).
Taken together these results demonstrate that ablation of tPA
affects the cerebrovascular bed as well as ventricular development
and ependymal integrity.
DISCUSSION
Thrombolytic treatment with tPA only benefits a limited
number of patients with ischemic stroke, and the limitations
appear to be due in part to unique activities of tPA in the
brain beyond its well established role in fibrinolysis (Nicole
et al., 2001; Wang et al., 2003; Yepes et al., 2003; Su et al.,
2009). Development of improved therapies for stroke will
therefore benefit from understanding the unique characteristics
of the role that endogenous tPA plays in the CNS. Previous
work has demonstrated an effect of tPA as a necessary and
sufficient regulator of cerebrovascular permeability and that
targeting tPA-induced opening of the BBB improves outcome
of disease (Yepes et al., 2003; Su et al., 2008; Fredriksson
et al., 2015). To advance our understanding of the role of
tPA in regulation of cerebrovascular integrity we performed
a detailed characterization of the cerebrovasculature in tPA
deficient mice. We demonstrate that tPA ablation leads
to reorganization of the vascular bed in the adult murine
brain, with a significant decrease in average vessel diameter,
mainly due to a reduction in the number of large and
medium sized vessels. These vessels are normally enveloped
by PDGFRα+ perivascular astrocytes (Fredriksson et al.,
2015), and we believe that the loss of these larger vessels
in tPA−/− brains accounts for the observed reduction in
vessel-associated PDGFRα expression. This is particularly
interesting since our previous work has shown that the
effect of tPA in regulation of cerebrovascular permeability
is mediated via tPA-catalyzed activation of PDGF-C, and
subsequently PDGFRα signaling on perivascular astrocytes
in the neurovascular unit (Fredriksson et al., 2004, 2005;
Su et al., 2008). The data presented here suggests that the
protection of barrier properties seen utilizing these tPA−/−
mice might be due, at least in part, to the cerebrovascular
rearrangements, further supporting our idea that tPA-
induced changes in cerebrovascular permeability proceeds
dysregulation of neuronal signaling pathways (Fredriksson
et al., 2015). In support of the notion, that congenital
cerebrovascular rearrangements contribute to increased
cerebrovascular integrity in tPA−/− mice, is our intriguing
observation that ablation of tPA results in increased number
of ERG-positive endothelial cells. Overexpression of this
endothelial transcription factor in vivo has recently been
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FIGURE 6 | Lateral ventricular defects and abnormal ependymal lining in the brains of tPA−/− mice. Lateral ventricular abnormalities (arrowheads) and
hypoplastic septum separating the lateral ventricles (LV; arrows) were seen in tPA−/− mice in (A) ex vivo sections visualized with DAPI and with (B) in vivo magnetic
resonance imaging (MRI) of WT and tPA−/− adult mice. (B) Montage from MR scans of an adult WT female mouse (upper panel) and two tPA−/− mice (middle
panels, images from a male adult tPA−/− mouse and lower panel, images from a female adult tPA−/− mouse). (C) Quantification of the ratio between the smallest to
the largest ventricular size from the MRI scans confirmed that tPA−/− mice (n = 13) displayed a significant asymmetry in lateral ventricular size as compared to WT
littermate controls (n = 10). The quantifications in (C) were made using Image J to trace the entire area of the right and left ventricle respectively. (D–H) Abnormal
ependymal lining of the LV in tPA−/− mice were revealed through immunofluorescent stainings and confocal microscopy on brain sections from WT (n = 5) and
tPA−/− (n = 5) mice. Analysis of the ependymal cell lining of the lateral wall of the LV was conducted using antibodies against S100B and Podocalyxin (Podo) (D),
GLUT1 (E–F) and ZO1 (G–H). Note the thicker ependymal lining in tPA−/− mice (arrows, D) compared to WT littermate controls (arrowheads, D) and the punctate
pattern of ZO1 staining in WT (arrowheads, G) compared to the continuous tight junctions between ependymal cells in tPA−/− mice (arrows, G). Quantification of
ependymal GLUT1 and ZO1 staining (between the dashed lines in E,G) by pixel intensity from six (GLUT1) and four (ZO1) maximum intensity confocal Z-stacks per
animal revealed an significant increase of both GLUT1 (F) and ZO1 (H) staining in the ventricular wall of tPA−/− mice compared to WT littermate controls. The data
shown are representative quantifications of two to six maximum intensity confocal Z-stacks per animal from two independent staining experiments. The images
display (A) stitched tiling of epifluorescent images (taken with 10× objective) and (D,E,G) maximum intensity projections generated from confocal Z-stacks (22 µm).
Each picture is a representative from different individuals. Cell nuclei were visualized with DAPI and vessels with podocalyxin (Podo) or CD31. Data presented as
(C) box-and-whiskers plot for distribution with min to max variance and F,H) mean ± SEM. Statistical significance was determined by student’s unpaired t-test and
∗P < 0.05; ∗∗P < 0.01 relative to control. Scale bars (A–B) 1 mm and (D,E,G) 20 µm. LV, Lateral ventricles. Arbitrary units; A.U.
shown to reduce vascular permeability during VEGF-induced
angiogenesis (Birdsey et al., 2015). It should be noted however,
that tPA is sufficient to directly control cerebrovascular
permeability, not only due to congenital rearrangements in
the cerebrovascular bed, since intraventricular injection of tPA
induces BBB opening in WT mice (Yepes et al., 2003). Further,
cerebrovascular permeability induced by experimental ischemic
stroke can be blocked by neuroserpin (Yepes et al., 2003),
the specific inhibitor of tPA in the brain (Fredriksson et al.,
2015).
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In addition to its role in regulation of cerebrovascular
permeability (Fredriksson et al., 2015), tPA has been implicated
in other cerebrovascular responses, including neurovascular
coupling (Park et al., 2008; Su et al., 2009). Neurovascular
coupling refers to increases in cerebral blood flow in response
to neuronal activity and ensures coupling between energy
demand and supply (Iadecola, 2004; Hamel, 2006). In the
study by Park et al. (2008) they utilized tPA−/− mice to
demonstrate that cerebral blood flow in the corresponding
barrel cortex of these mice showed a sustained attenuation
after whisker stimulation compared with WT mice. Another
study has recently demonstrated that neurovascular coupling
of local neural activity to local blood flow takes place
exclusively at ASMA+ SMC-covered arterioles, but not in
pericyte-covered capillaries (Hill et al., 2015). Interestingly,
tPA has been shown to be expressed around arterioles in
the CNS (Levin and del Zoppo, 1994; Su et al., 2008;
Fredriksson et al., 2015). Given the decreased number of
large diameter ASMA+ vessels observed in tPA−/− mice it
therefore seems plausible to suggest that the cerebrovascular
rearrangements associated with tPA ablation may explain
the attenuated neurovascular coupling response in tPA−/−
mice. Arguing against this are the findings that ectopic
administration of tPA to tPA−/−mice restored the neurovascular
coupling response (Park et al., 2008) and that in vivo
vasomotion in awake mice occurs in vessels covered by SMCs,
regardless of their diameter (Hill et al., 2015). In addition,
the add-back experiment (Park et al., 2008) implicates there
may be another downstream target of tPA than PDGFRα
signaling in the neurovascular coupling response since vessel-
associated expression of the receptor is reduced in tPA−/−
mice.
Our previous findings established a novel, previously
unknown, role for PDGF-C/PDGFRα signaling in
cerebroventricular development (Fredriksson et al., 2012).
This was later confirmed by a study showing that aberrant
PDGFRα signaling in primary cilia, and a subsequent loss of
NG2(+)PDGFRα(+) neural progenitor cells in the subventricular
zone, is associated with ventricular malformations (Carter
et al., 2012). The findings that tPA−/− mice displayed mild
cerebroventricular malformations is especially intriguing
since this provides an in vivo link between tPA and PDGF-C
signaling during CNS development. As reported for the PDGF-C
deficient (Pdgfc−/−) mice (Fredriksson et al., 2012), where
the smaller ventricle appeared to arise from displacement
of the septum, i.e., the structure separating the LV, this also
seemed to be the case in tPA−/− mice. The overall effect
on cerebroventricular assymmetry seemed less affected by
ablation of tPA compared to PDGF-C ablation. Our analysis did
however identify a few cases of severe assymetry and incomplete
development of the septum, a feature reminiscent of cavum
septum pellucidum in humans. A cavum of the septum is
often present at birth but eliminated as the septal leaves fuse
postnatally (Raine et al., 2010) and preservation of the cavum
in adults has been suggested to be due to underdevelopment
of limbic structures such as the hippocampus, amygdala and
septal nuclei (Nopoulos et al., 2000; Kim et al., 2007), places
where high expression of tPA is seen. Contrary to our earlier
study, showing that PDGF-C ablation causes defects in the
ependymal lining of the LV, including ependymal denudation
and reduced expression of GLUT1 in the ventricular wall
(Fredriksson et al., 2012), we did not find any signs of ependymal
denudation in tPA−/− mice and instead noted an increase in
ventricular expression of GLUT1 and ZO1. This is indicative
of a more mature ventricular lining with higher integrity
in tPA−/− mice compared to WT littermate controls and
Pdgfc−/− mice. The opposing effects of tPA and PDGF-C
ablation on ependymal development, and in cerebrovascular
development where Pdgfc−/− mice, contrary to tPA−/− mice,
display a significant overall increase in vessel diameter and
ASMA+ expression, suggests additional, independent roles,
of the two in cerebral development. Whether the congenital
defects observed in tPA−/− mice are directly controlled by tPA-
mediated processes, or an indirect consequence of tPA ablation,
remains to be established. It will therefore be interesting to
utilize the tPA−/− mice, Pdgfc−/− mice (Fredriksson et al.,
2012) and conditional PDGFRα knockout mice (Carter et al.,
2012) to further unravel aspects and underlying molecular
mechanisms of cerebral vascular, ventricular and ependymal
development.
In conclusion, our data demonstrate that tPA plays an
important role in normal cerebral vascularization and normal
cerebral ventricular formation. Thus, this study enhances
our understanding of the role of tPA in the CNS, in
particular the role in regulation of cerebrovascular integrity, and
might help explain how vascular barrier defects contribute to
stroke evolution. In addition, since increased cerebrovascular
permeability constitutes a significant pathologic factor in the
development of other neurologic diseases, including seizures
(Friedman et al., 2009) and traumatic brain injury (Shlosberg
et al., 2010), and since tPA-mediated PDGFRα signaling
has been implicated in regulation of vascular integrity in
these diseases (Fredriksson et al., 2015; Su et al., 2015), our
findings might be of importance not only for stroke but
also for unrelated CNS disorders where vascular integrity is
compromised.
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